SCHEMBL127793

SCHEMBL127793

On1[c]ncc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8919417 0.63
SCHEMBL4923247 0.62
SCHEMBL20298922 0.62
SCHEMBL2425815 0.61
SCHEMBL5270457 0.60
SCHEMBL1020956 0.57
SCHEMBL423113 0.57
SCHEMBL8487795 0.57
SCHEMBL10578969 0.57
SCHEMBL4932702 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 883 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240002549-A1 REACTIVE POLYSACCHARIDE-BASED HEMOSTATIC AGENT DAVOL INC. (US) 2024-01-04 US claimed
EP-4267210-A1 REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A PROTEIN AND A MULTIFUNCTIONALIZED MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT Davol Inc. (US) 2023-11-01 EP claimed
CN-116744984-A Reactive dry powder hemostatic material comprising protein and a multi-functionally modified polyethylene glycol-based crosslinker 达沃有限公司 2023-09-12 CN claimed
US-11739166-B2 Reactive polysaccharide-based hemostatic agent DAVOL INC. (US) 2023-08-29 US claimed
US-20230094351-A1 REACTIVE HYDROGEL FORMING FORMULATIONS AND RELATED METHODS, INCLUDING METHODS OF PREPARATION BARD PERIPHERAL VASCULAR, INC. (US) 2023-03-30 US claimed
EP-4121131-A1 REACTIVE HYDROGEL FORMING FORMULATIONS AND RELATED METHODS Bard Peripheral Vascular, Inc. (US) 2023-01-25 EP claimed
CN-115515653-A Reactive hydrogel-forming formulations and related methods 巴德外周血管股份有限公司 2022-12-23 CN claimed
CN-110713588-B Hardmask composition, hardmask layer and method of forming pattern 三星SDI株式会社 2022-08-09 CN claimed
WO-2022146917-A1 REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A PROTEIN AND A MULTIFUNCTIONALIZED MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT DAVOL INC. (US) 2022-07-07 WO claimed
US-20220211900-A1 REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A PROTEIN AND A MULTIFUNCTIONALIZED MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT DAVOL INC. (US) 2022-07-07 US claimed
WO-2009061879-A1 PEPTIDE DEFORMYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-05-14 WO claimed
WO-2008153784-A2 HYDROXYBENZYL OR HYDROXYPYRANONEMETHYL ESTERS AS TYROSINASE INHIBITORS EASTMAN CHEMICAL COMPANY (US) 2008-12-18 WO claimed
US-20080306144-A1 Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors EASTMAN CHEMICAL COMPANY 2008-12-11 US claimed
WO-2008143777-A1 HYDROQUINONE DERIVATIVE SKIN BRIGHTENING COMPOUNDS EASTMAN CHEMICAL COMPANY (US) 2008-11-27 WO claimed
US-20080286219-A1 Hydroquinone derivative skin brightening compounds EASTMAN CHEMICAL COMPANY 2008-11-20 US claimed
EP-1301187-B1 PURINE-2,6-DIONES WHICH ARE INHIBITORS OF THE ENZYME DIPEPTIDYL PEPTIDASE IV (DPP-IV) NOVO NORDISK AS (DK) 2005-07-06 EP claimed
US-6576263-B2 Crosslinked polymer 3M INNOVATIVE PROPERTIES COMPANY 2003-06-10 US claimed
EP-1257257-A2 DELIVERY SYSTEMS USING PREFORMED BIODEGRADABLE POLYMER COMPOSITIONS AND METHODS 3M Innovative Properties Company (US) 2002-11-20 EP claimed
US-20020009492-A1 Delivery systems using preformed biodegradable polymer compositions and methods 3M INNOVATIVE PROPERTIES COMPANY 2002-01-24 US claimed
WO-2001060335-A2 DELIVERY SYSTEMS USING PREFORMED BIODEGRADABLE POLYMER COMPOSITIONS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2001-08-23 WO claimed